BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24050387)

  • 1. Malignant H1299 tumour cells preferentially internalize iron-bound inositol hexakisphosphate.
    Helmis C; Blechner C; Lin H; Schweizer M; Mayr GW; Nielsen P; Windhorst S
    Biosci Rep; 2013 Oct; 33(5):. PubMed ID: 24050387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siderophore activity of myo-inositol hexakisphosphate in Pseudomonas aeruginosa.
    Smith AW; Poyner DR; Hughes HK; Lambert PA
    J Bacteriol; 1994 Jun; 176(12):3455-9. PubMed ID: 8206821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour cells can employ extracellular Ins(1,2,3,4,5,6)P(6) and multiple inositol-polyphosphate phosphatase 1 (MINPP1) dephosphorylation to improve their proliferation.
    Windhorst S; Lin H; Blechner C; Fanick W; Brandt L; Brehm MA; Mayr GW
    Biochem J; 2013 Feb; 450(1):115-25. PubMed ID: 23186306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intracellular distribution of inositol polyphosphates in HL60 promyeloid cells.
    Stuart JA; Anderson KL; French PJ; Kirk CJ; Michell RH
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):517-25. PubMed ID: 7980412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexakisphosphate.
    Hawkins PT; Poyner DR; Jackson TR; Letcher AJ; Lander DA; Irvine RF
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):929-34. PubMed ID: 8379947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.
    Kitchen E; Condliffe AM; Rossi AG; Haslett C; Chilvers ER
    Br J Pharmacol; 1996 Mar; 117(5):979-85. PubMed ID: 8851521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular and extracellular myo-inositol hexakisphosphate (InsP6), from rats to humans.
    Grases F; Costa-Bauza A; Prieto RM
    Anticancer Res; 2005; 25(3c):2593-7. PubMed ID: 16080499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol hexakisphosphate binding sites in rat heart and brain.
    Rowley KG; Gundlach AL; Cincotta M; Louis WJ
    Br J Pharmacol; 1996 Aug; 118(7):1615-20. PubMed ID: 8842422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol hexakisphosphate increases the size of platelet aggregates.
    Brehm MA; Klemm U; Rehbach C; Erdmann N; Kolšek K; Lin H; Aponte-Santamaría C; Gräter F; Rauch BH; Riley AM; Mayr GW; Potter BVL; Windhorst S
    Biochem Pharmacol; 2019 Mar; 161():14-25. PubMed ID: 30557554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dephosphorylation of myo-inositol phosphates in the in vitro intestinal Caco-2 cell model.
    Briviba K; Schollenberger M; Rodehutscord M; Greiner R
    Int J Food Sci Nutr; 2018 Feb; 69(1):46-51. PubMed ID: 28554270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New options of cancer treatment employing InsP
    Brehm MA; Windhorst S
    Biochem Pharmacol; 2019 May; 163():206-214. PubMed ID: 30797871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inositol hexakisphosphate binds to clathrin assembly protein 3 (AP-3/AP180) and inhibits clathrin cage assembly in vitro.
    Norris FA; Ungewickell E; Majerus PW
    J Biol Chem; 1995 Jan; 270(1):214-7. PubMed ID: 7814377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of inositol hexaphosphate and its Ni(II) complex on human acute leukemia Jurkat T cells.
    de Lima EM; Kanunfre CC; de Andrade LF; Granato D; Rosso ND
    Toxicol In Vitro; 2015 Dec; 29(8):2081-8. PubMed ID: 26335902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol hexakisphosphate-mediated regulation of glutamate receptors in rat brain sections.
    Valastro B; Girard M; Gagné J; Martin F; Parent AT; Baudry M; Massicotte G
    Hippocampus; 2001; 11(6):673-82. PubMed ID: 11811661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of inositol phosphate-dependent mobility of Ku: depletion of the DNA-PK cofactor InsP6 inhibits Ku mobility.
    Byrum J; Jordan S; Safrany ST; Rodgers W
    Nucleic Acids Res; 2004; 32(9):2776-84. PubMed ID: 15150344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated exocytosis of insulin by activation of protein kinase C.
    Efanov AM; Zaitsev SV; Berggren PO
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4435-9. PubMed ID: 9114007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of inositol hexakisphosphate (InsP6) protect HEK293 cells from tumor necrosis factor (alpha)- and Fas-induced apoptosis.
    Verbsky J; Majerus PW
    J Biol Chem; 2005 Aug; 280(32):29263-8. PubMed ID: 15967797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
    Grases F; Isern B; Perelló J; Sanchis P; Prieto RM
    Front Biosci; 2005 Jan; 10():799-802. PubMed ID: 15569619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid).
    Sakamoto K; Venkatraman G; Shamsuddin AM
    Carcinogenesis; 1993 Sep; 14(9):1815-9. PubMed ID: 7691427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.